celiprolol has been researched along with Airflow Obstruction, Chronic in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Excerpt | Relevance | Reference |
---|---|---|
" No significant adverse effects occurred." | 3.30 | Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study. ( Anderson, W; Lipworth, BJ; Ross, R; Short, P, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, W | 1 |
Short, P | 1 |
Ross, R | 1 |
Lipworth, BJ | 1 |
van der Woude, HJ | 1 |
Zaagsma, J | 1 |
Postma, DS | 1 |
Winter, TH | 1 |
van Hulst, M | 1 |
Aalbers, R | 1 |
Salpeter, S | 2 |
Ormiston, T | 2 |
Salpeter, E | 2 |
2 reviews available for celiprolol and Airflow Obstruction, Chronic
Article | Year |
---|---|
Cardioselective beta-blocker use in patients with reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Human | 2001 |
Cardioselective beta-blockers for reversible airway disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Human | 2002 |
2 trials available for celiprolol and Airflow Obstruction, Chronic
Article | Year |
---|---|
Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study.
Topics: Bisoprolol; Celiprolol; Cross-Over Studies; Exercise Tolerance; Humans; Pulmonary Disease, Chronic O | 2023 |
Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Bronchial Hyperreactivity; Bronc | 2005 |